Korean J Hepatobiliary Pancreat Surg.  2012 May;16(2):59-64. 10.14701/kjhbps.2012.16.2.59.

Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer

• Lee SH
• Yang JD
• Hwang HP
• Yu HC
• Cho BH

• KMID: 2083324
• DOI: http://doi.org/10.14701/kjhbps.2012.16.2.59

Abstract

BACKGROUNDS/AIMS
The aim of this study is to analyze surgical outcomes and prognostic factors affecting survival after surgical resection in patients with gallbladder cancer.
METHODS
We retrospectively reviewed 86 patients treated surgically for gallbladder cancer from January 2000 to December 2009 at Chonbuk National University Hospital. Clinicopathologic factors, surgical treatment and outcome data were analyzed.
RESULTS
Among the 86 patients (44 male, 42 female) with gallbladder cancer, the mean age was 62.9 years (range: 32-80) and the median survival was 42.4+/-3.5 month. The overall cumulative survival rates of 86 patients were for 1 year, 83.7%; 3 year, 67.4%; 5 year survival, 61.7%. Univariate analysis revealed that preoperative serum alanine aminotransferase, alkaline phosphatase, total bilirubin, carcinoembryonic antigen (CEA), T staging, N staging were statistically significantly associated with survival. CEA (p=0.004) and T staging (p=0.005) were associated with survival in multivariate analysis. Two-year survival rates were analyzed according to the methods of surgical resection, with simple cholecystectomy showing 100%, whereas extended cholecystectomy showed about 83% in T1b. We could not find out any adverse effect of the simple cholecystectomy for survival.
CONCLUSIONS
CEA and T stage are independent significant prognostic factor associated with patient survival in our study. Simple cholecystectomy can be regarded as curative resection in stage T1b. Longer observation periods and more cases will be needed to confirm these conclusions.

Keyword

Gallbladder cancer; Prognostic factors; Survival rate

MeSH Terms

Alanine Transaminase
Alkaline Phosphatase
Bilirubin
Carcinoembryonic Antigen
Cholecystectomy
Gallbladder
Gallbladder Neoplasms
Humans
Male
Multivariate Analysis
Retrospective Studies
Survival Rate
Alanine Transaminase
Alkaline Phosphatase
Bilirubin
Carcinoembryonic Antigen

Reference

1. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011. 43:1–11.

2. Zhu AX, Hong TS, Hezel AF, et al. Current management of gallbladder carcinoma. Oncologist. 2010. 15:168–181.

3. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg. 1994. 219:275–280.

4. Smith GC, Parks RW, Madhavan KK, et al. A 10-year experience in the management of gallbladder cancer. HPB (Oxford). 2003. 5:159–166.

5. Moon HH, Yoon M. The survival rate of gallbladder carcinoma based on the presence of lymph node metastasis and the depth of the primary tumor invasion. Korean J Hepatobiliary Pancreat Surg. 2008. 12:128–133.

6. Konstantinidis IT, Deshpande V, Genevay M, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009. 144:441–447.

7. Liang JW, Dong SX, Zhou ZX, et al. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years. Chin Med J (Engl). 2008. 121:1900–1905.

8. Chan SY, Poon RT, Lo CM, et al. Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol. 2008. 97:156–164.

9. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003. 4:167–176.

10. Chakravarty KD, Yeh CN, Jan YY, et al. Factors influencing long-term survival in patients with T3 gallbladder adenocarcinoma. Digestion. 2009. 79:151–157.

11. Park JI, Kim JS, Kim KH, et al. Analysis of prognostic factors affecting survival in patients with gallbladder cancer. Korean J Hepatobiliary Pancreat Surg. 2010. 14:173–183.

12. Kang SY, Lee SK, Kim JY, et al. Clinical features and prognostic factors influencing long-term survival in pT2 gallbladder carcinoma patients. Korean J Hepatobiliary Pancreat Surg. 2008. 12:173–179.

13. Abramson MA, Pandharipande P, Ruan D, et al. Radical resection for T1b gallbladder cancer: a decision analysis. HPB (Oxford). 2009. 11:656–663.

14. Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011. 17:174–180.

15. Pilgrim C, Usatoff V, Evans PM. A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour. Eur J Surg Oncol. 2009. 35:903–907.

16. Kohya N, Kitahara K, Miyazaki K. Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread. World J Gastroenterol. 2010. 16:3567–3572.

17. Kondo S, Takada T, Miyazaki M, et al. Japanese Association of Biliary Surgery. Japanese Society of Hepato-Biliary-Pancreatic Surgery. Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008. 15:41–54.